80 FR 46040 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 80, Issue 148 (August 3, 2015)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 80, Issue 148 (August 3, 2015)
| Page Range | 46040-46042 | |
| FR Document | 2015-18948 |
[Federal Register Volume 80, Number 148 (Monday, August 3, 2015)] [Notices] [Pages 46040-46042] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-18948] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http://www.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and [[Page 46041]] specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated November 25, 2008 (73 FR 71858), the following HHS-certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities Dynacare, 6628 50th Street NW, Edmonton, AB Canada T6B 2N7, 780-784- 1190, (Formerly: Gamma-Dynacare Medical Laboratories). HHS-Certified Laboratories ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 585-429-2264. Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 37210, 615-255-2400, (Formerly: Aegis Sciences Corporation, Aegis Analytical Laboratories, Inc., Aegis Analytical Laboratories). Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361- 8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.). Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130, (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.). Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little Rock, AR 72209-7056, 501-202-2783, (Formerly: Forensic Toxicology Laboratory Baptist Medical Center). Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802, 800- 445-6917. DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800- 235-4890. Dynacare*, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679- 1630, (Formerly: Gamma-Dynacare Medical Laboratories). ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609. Fortes Laboratories, Inc., 25749 SW Canyon Creek Road, Suite 600, Wilsonville, OR 97070, 503-486-1023. Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical Laboratories, Inc.). Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group). Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866-827-8042/800-233-6339, (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center). LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845, (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.). MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory). Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology Laboratory). Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509-755-8991/800-541-7891x7. Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635- 5840. Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 800-729-6432, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 91304, 818-737-6370, (Formerly: SmithKline Beecham Clinical Laboratories). Redwood Toxicology Laboratory, 3700650 Westwind Blvd., Santa Rosa, CA 95403, 800-255-2159. Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040, 602-438-8507/800-279-0027. STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421, 800-442-0438. US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085. * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 30, 2010 (75 FR 22809). After receiving DOT certification, the laboratory will be [[Page 46042]] included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Summer King, Statistician. [FR Doc. 2015-18948 Filed 7-31-15; 8:45 am] BILLING CODE 4160-20-P
![46040 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
Time: 1:00 p.m. to 3:00 p.m. Name of Committee: National Heart, Lung, DEPARTMENT OF HEALTH AND
Agenda: To review and evaluate grant and Blood Institute, Special Emphasis Panel, HUMAN SERVICES
applications. Science Moving TowArds Research
Place: National Institutes of Health, 6701 Translation and Therapy (SMARTT), Substance Abuse and Mental Health
Rockledge Drive, Bethesda, MD 20892, Biologics Production Facility (PF), Program
(Telephone Conference Call).
Services Administration
Extension.
Contact Person: Shiv A. Prasad, Ph.D.,
Date: August 25, 2015. Current List of HHS-Certified
Scientific Review Officer, Center for
Scientific Review, National Institutes of Time: 3:30 p.m. to 4:00 p.m. Laboratories and Instrumented Initial
Health, 6701 Rockledge Drive, Room 5220, Agenda: To review and evaluate contract Testing Facilities Which Meet Minimum
MSC 7852, Bethesda, MD 20892, 301–443– proposals. Standards To Engage in Urine Drug
5779, prasads@csr.nih.gov. Place: National Institutes of Health, 6701 Testing for Federal Agencies
This notice is being published less than 15 Rockledge Drive, Room 7185, Bethesda, MD
days prior to the meeting due to the timing 20892, (Telephone Conference Call). AGENCY: Substance Abuse and Mental
limitations imposed by the review and Contact Person: Kristen Page, Ph.D., Health Services Administration, HHS.
funding cycle. Scientific Review Officer, Office of Scientific ACTION: Notice.
(Catalogue of Federal Domestic Assistance Review/DERA, National Heart, Lung, and
Program Nos. 93.306, Comparative Medicine; Blood Institute, 6701 Rockledge Drive, Room SUMMARY: The Department of Health and
93.333, Clinical Research, 93.306, 93.333, 7185, Bethesda, MD 20892, 301–435–0725, Human Services (HHS) notifies federal
93.337, 93.393–93.396, 93.837–93.844, kristen.page@nih.gov. agencies of the laboratories and
93.846–93.878, 93.892, 93.893, National Instrumented Initial Testing Facilities
Institutes of Health, HHS). Name of Committee: National Heart, Lung,
and Blood Institute, Special Emphasis Panel, (IITF) currently certified to meet the
Dated: July 28, 2015. Science Moving TowArds Research standards of the Mandatory Guidelines
Michelle Trout, Translation and Therapy (SMARTT), Non- for Federal Workplace Drug Testing
Program Analyst, Office of Federal Advisory Biological Production Facility (PF), Program Programs (Mandatory Guidelines). The
Committee Policy. Extension. Mandatory Guidelines were first
[FR Doc. 2015–18875 Filed 7–31–15; 8:45 am] Date: August 25, 2015. published in the Federal Register on
BILLING CODE 4140–01–P Time: 4:00 p.m. to 4:30 p.m. April 11, 1988 (53 FR 11970), and
Agenda: To review and evaluate contract subsequently revised in the Federal
proposals. Register on June 9, 1994 (59 FR 29908);
DEPARTMENT OF HEALTH AND Place: National Institutes of Health, 6701 September 30, 1997 (62 FR 51118);
HUMAN SERVICES Rockledge Drive, Room 7185, Bethesda, MD April 13, 2004 (69 FR 19644); November
20892, (Telephone Conference Call).
25, 2008 (73 FR 71858); December 10,
National Institutes of Health Contact Person: Kristen Page, Ph.D.,
2008 (73 FR 75122); and on April 30,
Scientific Review Officer, Office of Scientific
2010 (75 FR 22809).
National Heart, Lung, and Blood Review/DERA, National Heart, Lung, and
A notice listing all currently HHS-
Institute; Notice of Closed Meetings Blood Institute, 6701 Rockledge Drive, Room
7185, Bethesda, MD 20892, 301–435–0725,
certified laboratories and IITFs is
Pursuant to section 10(d) of the kristen.page@nih.gov. published in the Federal Register
Federal Advisory Committee Act, as during the first week of each month. If
Name of Committee: National Heart, Lung,
amended (5 U.S.C. App.), notice is any laboratory or IITF certification is
and Blood Institute, Special Emphasis Panel,
hereby given of the following meetings. Science Moving TowArds Research
suspended or revoked, the laboratory or
The meetings will be closed to the Translation and Therapy (SMARTT), IITF will be omitted from subsequent
public in accordance with the Pharmacology and Toxicology, Program lists until such time as it is restored to
provisions set forth in sections Extension. full certification under the Mandatory
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Date: August 25, 2015. Guidelines.
as amended. The contract proposals and Time: 4:30 p.m. to 5:00 p.m. If any laboratory or IITF has
the discussions could disclose Agenda: To review and evaluate contract withdrawn from the HHS National
confidential trade secrets or commercial proposals. Laboratory Certification Program (NLCP)
property such as patentable material, Place: National Institutes of Health, 6701 during the past month, it will be listed
and personal information concerning Rockledge Drive, Room 7185, Bethesda, MD at the end and will be omitted from the
individuals associated with the contract 20892, (Telephone Conference Call). monthly listing thereafter.
proposals, the disclosure of which Contact Person: Kristen Page, Ph.D., This notice is also available on the
would constitute a clearly unwarranted Scientific Review Officer, Office of Scientific Internet at http://www.samhsa.gov/
invasion of personal privacy. Review/DERA, National Heart, Lung, and workplace.
Blood Institute, 6701 Rockledge Drive, Room
Name of Committee: National Heart, Lung, FOR FURTHER INFORMATION CONTACT:
7185, Bethesda, MD 20892, 301–435–0725,
and Blood Institute Special Emphasis Panel, Giselle Hersh, Division of Workplace
kristen.page@nih.gov.
Science Moving TowArds Research Programs, SAMHSA/CSAP, Room 7–
Translation and Therapy (SMARTT), (Catalogue of Federal Domestic Assistance 1051, One Choke Cherry Road,
Coordinating Center—Program Extension. Program Nos. 93.233, National Center for
Rockville, Maryland 20857; 240–276–
Date: August 25, 2015. Sleep Disorders Research; 93.837, Heart and
Time: 3:00 p.m. to 3:30 p.m.
2600 (voice), 240–276–2610 (fax).
Vascular Diseases Research; 93.838, Lung
Agenda: To review and evaluate contract Diseases Research; 93.839, Blood Diseases SUPPLEMENTARY INFORMATION: The
proposals. and Resources Research, National Institutes Mandatory Guidelines were initially
mstockstill on DSK4VPTVN1PROD with NOTICES
Place: National Institutes of Health, 6701 of Health, HHS) developed in accordance with Executive
Rockledge Drive, Room 7185, Bethesda, MD Order 12564 and section 503 of Public
20892, (Telephone Conference Call). Dated: July 28, 2015.
Law 100–71. The ‘‘Mandatory
Contact Person: Kristen Page, Ph.D., Michelle Trout,
Scientific Review Officer, Office of Scientific
Guidelines for Federal Workplace Drug
Program Analyst, Office of Federal Advisory Testing Programs,’’ as amended in the
Review/DERA, National Heart, Lung, and Committee Policy.
Blood Institute, 6701 Rockledge Drive, Room revisions listed above, requires strict
7185, Bethesda, MD 20892, 301–435–0725, [FR Doc. 2015–18874 Filed 7–31–15; 8:45 am] standards that laboratories and IITFs
kristen.page@nih.gov. BILLING CODE 4140–01–P must meet in order to conduct drug and
VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 E:\FR\FM\03AUN1.SGM 03AUN1](https://thefederalregister.org/doc/80_FR_46188/page/1.svg)
![46042 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
included in the monthly list of HHS- not consider requests or comments sent agencies to promote openness and
certified laboratories and participate in to an email or address not listed under transparency in Government by
the NLCP certification maintenance ADDRESSES. If you provide an email disclosing information to the public, we
program. address in your request for copies of invite public comment on these permit
applications, we will attempt to respond applications before final action is taken.
Summer King,
to your request electronically. Under the MMPA, you may request a
Statistician. Please make your requests or hearing on any MMPA application
[FR Doc. 2015–18948 Filed 7–31–15; 8:45 am] comments as specific as possible. Please received. If you request a hearing, give
BILLING CODE 4160–20–P confine your comments to issues for specific reasons why a hearing would be
which we seek comments in this notice, appropriate. The holding of such a
and explain the basis for your hearing is at the discretion of the
DEPARTMENT OF THE INTERIOR comments. Include sufficient Service Director.
information with your comments to
Fish and Wildlife Service allow us to authenticate any scientific or III. Permit Applications
[FWS–HQ–IA–2015–N146; commercial data you include. A. Endangered Species
FXIA16710900000–156–FF09A30000] The comments and recommendations
that will be most useful and likely to Applicant: KJC Holdings LP, Lohn, TX;
Endangered Species; Marine influence agency decisions are: (1) PRT–200211
Mammals; Receipt of Applications for Those supported by quantitative The applicant requests a permit for
Permit information or studies; and (2) Those cull and take of excess barasingha
that include citations to, and analyses (Rucervus duvaucelii) for the purpose of
AGENCY: Fish and Wildlife Service,
of, the applicable laws and regulations. enhancement of the survival of the
Interior.
We will not consider or include in our species. This notification covers
ACTION: Notice of receipt of applications administrative record comments we activities to be conducted by the
for permit. receive after the close of the comment applicant over a 5-year period.
SUMMARY: We, the U.S. Fish and period (see DATES) or comments
delivered to an address other than those Applicant: Fleming Creative Concept
Wildlife Service, invite the public to LLC, Scottsdale, AZ; PRT–65772B
comment on the following applications listed above (see ADDRESSES).
The applicant requests a permit for
to conduct certain activities with B. May I review comments submitted by
interstate transport of 10 jackass
endangered species, marine mammals, others?
penguins (Spheniscus demersus) from
or both. With some exceptions, the Comments, including names and the Six Flags Discovery Kingdom,
Endangered Species Act (ESA) and street addresses of respondents, will be Vallejo, California to Miami
Marine Mammal Protection Act available for public review at the street Seaquarium, Miami, Florida, for the
(MMPA) prohibit activities with listed address listed under ADDRESSES. The purpose of enhancement of the survival
species unless Federal authorization is public may review documents and other of the species. This notification covers
acquired that allows such activities. information applicants have sent in activities to be conducted by the
DATES: We must receive comments or support of the application unless our applicant over a 5-year period.
requests for documents on or before allowing viewing would violate the
September 2, 2015. We must receive Privacy Act or Freedom of Information Applicant: Earth Promise, Glen Rose,
requests for marine mammal permit Act. Before including your address, TX; PRT–59071B
public hearings, in writing, at the phone number, email address, or other The applicant requests a permit to
address shown in the ADDRESSES section personal identifying information in your export two scimitar-horned oryx (Oryx
by September 2, 2015. comment, you should be aware that dammah) and two addaxes (Addax
ADDRESSES: Brenda Tapia, U.S. Fish and your entire comment—including your nasomaculatus) born in captivity to
Wildlife Service, Division of personal identifying information—may African Lion Safari, Ontario, Canada, for
Management Authority, Branch of be made publicly available at any time. the purpose of enhancement of the
Permits, MS: IA, 5275 Leesburg Pike, While you can ask us in your comment survival of the species.
Falls Church, VA 22041; fax (703) 358– to withhold your personal identifying
Applicant: Barefoot Zoological, dba
2281; or email DMAFR@fws.gov. information from public review, we
Alligator Adventure, North Myrtle
FOR FURTHER INFORMATION CONTACT: cannot guarantee that we will be able to
Beach, SC; PRT–141742
Brenda Tapia, (703) 358–2104 do so.
(telephone); (703) 358–2281 (fax); The applicant requests renewal of a
II. Background captive-bred wildlife registration under
DMAFR@fws.gov (email).
To help us carry out our conservation 50 CFR 17.21(g) for the following
SUPPLEMENTARY INFORMATION:
responsibilities for affected species, and species to enhance species propagation
I. Public Comment Procedures in consideration of section 10(a)(1)(A) of or survival: Ring-tailed lemur (Lemur
the Endangered Species Act of 1973, as catta), red ruffed lemur (Varecia rubra),
A. How do I request copies of amended (16 U.S.C. 1531 et seq.), and black and white ruffed lemur (Varecia
applications or comment on submitted the Marine Mammal Protection Act of variegata), Chinese alligator (Alligator
applications? 1972, as amended (16 U.S.C. 1361 et sinensis), Nile crocodile (Crocodylus
mstockstill on DSK4VPTVN1PROD with NOTICES
Send your request for copies of seq.), along with Executive Order 13576, niloticus), saltwater crocodile
applications or comments and materials ‘‘Delivering an Efficient, Effective, and (Crocodylus porosus), common caiman
concerning any of the applications to Accountable Government,’’ and the (Caiman crocodilus crocodilus), brown
the contact listed under ADDRESSES. President’s Memorandum for the Heads caiman (Caiman crocodilus fuscus),
Please include the Federal Register of Executive Departments and Agencies Cuban crocodile (Crocodylus
notice publication date, the PRT- of January 21, 2009—Transparency and rhombifer), Siamese crocodile
number, and the name of the applicant Open Government (74 FR 4685; January (Crocodylus siamensis), Yacare (Caiman
in your request or submission. We will 26, 2009), which call on all Federal yacare), dwarf crocodile (Osteolaemus
VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 E:\FR\FM\03AUN1.SGM 03AUN1](https://thefederalregister.org/doc/80_FR_46188/page/3.svg)
Document Created: 2018-02-23 10:51:16
Document Modified: 2018-02-23 10:51:16
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax). | |
| FR Citation | 80 FR 46040 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR